— Know what they know.
Not Investment Advice
Also trades as: BSX-PA (NYSE) · $vol 22M · 0HOY.L (LSE) · $vol 1M · BSX.F (FSX) · $vol 0M

BSX NYSE

Boston Scientific Corporation
1W: +1.2% 1M: +3.8% 3M: -1.0% YTD: -51.9% 1Y: -55.5% 3Y: -9.8% 5Y: +6.5%
$45.08
-0.51 (-1.11%)
After Hours: $45.15 (+0.07, +0.17%)
Weekly Expected Move ±3.5%
$42 $44 $46 $47 $49
NYSE · Healthcare · Medical - Devices · Tech Score Buy · Power 71 · $66.1B mcap · 1.44B float · 1.35% daily turnover · Short 45% of daily vol
Credit Risk of going bust: lower than 62% of companies Debt: 16.0% of company value Bonds: $51.9M held by 128 funds, 63 bp over Treasuries → details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.79 (down 98%), Boston Scientific Corporation would be worth roughly what it owes.
Total debt $12.62B against a stock market value of $66.06B.
Distance to default 6.42 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $7.10B (short-term plus half of long-term), stock volatility 39.6%; Altman Z 3.05. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.

📊 Key Metrics

TTM
$21B
Revenue
+13.5% YoY
$4B
Net Income
+46.6% YoY
$4B
Free Cash Flow
+9.5% YoY
70.7%
Gross Margin
21.6%
Op. Margin
16.7%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE15.5%
ROA8.5%
ROIC11.6%

Valuation

P/E18.1
P/B2.7
EV/EBITDA13.0

Leverage

Debt/Equity0.51
Current Ratio1.24
Interest Cov.12.1x

Quality Scores

Piotroski F8/9
Altman Z2.96
Beneish M-2.49

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms